Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000832

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Total Liabilities Q1 2022 · Dec 31, 2021 $578.59K
Total Liabilities Q1 2022 · Sep 30, 2021 $587.34K
Total Assets Q1 2022 · Dec 31, 2021 $193.05K
Total Assets Q1 2022 · Sep 30, 2021 $261.15K
Operating Cash Flow Q1 2022 · Dec 31, 2020 −$30
Operating Income Q1 2022 · Dec 31, 2020 −$4.97K